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Abstract
Sox9 is an high-mobility group box transcription factor that is expressed in the stem cell zone of the small
intestine and colon. We have previously used a Sox9EGFP mouse model to demonstrate that discrete levels
of Sox9 expression mark small intestine epithelial stem cells that form crypt/villus-like structures in a three-
dimensional culture system (Formeister EJ, Sionas AL, Lorance DK, Barkley CL, Lee GH, Magness ST.
Am J Physiol Gastrointest Liver Physiol 296: G1108–G1118, 2009; Gracz AD, Ramalingam S, Magness
ST. Am J Physiol Gastrointest Liver Physiol 298: G590–G600, 2010). In the present study, we
hypothesized that discrete levels of Sox9 expression would also mark colonic epithelial stem cells (CESCs).
Using the Sox9EGFP mouse model, we show that lower levels of Sox9 mark cells in the transit-amplifying
progenitor cell zone, while higher levels of Sox9 mark cells in the colonic crypt base. Furthermore, we
demonstrate that variable SOX9 levels persist in cells of colonic adenomas from mice and humans. Cells
expressing lower Sox9 levels demonstrate gene expression profiles consistent with more differentiated
populations, and cells expressing higher Sox9 levels are consistent with less differentiated populations.
When placed in culture, cells expressing the highest levels of Sox9 formed “colonoids,” which are defined
as bodies of cultured colonic epithelial cells that possess multiple cryptlike structures and a pseudolumen.
Cells expressing the highest levels of Sox9 also demonstrate multipotency and self-renewal in vitro,
indicating functional stemness. These data suggest a dose-dependent role for Sox9 in normal CESCs and
cells comprising colon tumors. Furthermore, distinct Sox9 levels represent a new biomarker to study CESC
and progenitor biology in physiological and disease states.
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ൿඈඋ ൽൾർൺൽൾඌ, ඍඁൾ ඀ൾඇൾඋൺඅ උൾ඀ංඈඇ of the intestinal epithelial stem cell (IESC) niche in the small
intestine and colon has been recognized to exist in the crypts (5, 31); however, the lack of specific
biomarkers that can be used to identify and isolate IESCs has been a challenge to the study of IESCs during
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physiological states, disease, and injury. Recent studies have identified genes that exhibit restricted
expression in the IESC zones of the small intestine, suggesting that they might serve as stem cell
biomarkers (12, 26, 37, 39, 41). In vivo genetic lineage tracing studies in mice have demonstrated that the
G protein-coupled receptor Lgr5, cell surface marker CD133, polycomb ring finger oncogene Bmi1, and
telomerase (Tert) mark a population of IESCs in the crypt base of the small intestine. Additionally, the cell
surface marker CD24 has been shown to be useful for fluorescent-activated cell sorting (FACS) enrichment
of a small intestine IESC population that possesses stem cell characteristics, which are defined by
multipotency and self-renewal capacity in vitro (15, 44). Other studies in the small intestine have correlated
gene expression patterns of Ascl2, Olfm4, Musashi1, and Dcamkl1 to IESC zone (17, 22, 30, 42, 43);
however, it is still unclear whether these genes mark cells that possess functional stem cell properties based
on in vivo lineage tracing or in vitro culture of FACS isolated cells.
Our laboratory has previously demonstrated that distinct Sox9 expression levels are useful biomarkers in
the identification and isolation of different small intestine epithelial cell lineages, including IESCs (15).
Using a Sox9EGFP mouse model in which enhanced green fluorescent protein (EGFP) is driven by large
regulatory regions of the Sox9 5′-flanking regions, we demonstrated that “high” Sox9EGFP levels mark
chromogranin A-positive cells, which are consistent with enteroendocrine lineages; “low” levels mark
IESCs, and “sublow” levels mark transit-amplifying progenitor cells (10, 15). Furthermore, we
demonstrated functional stem cell characteristics of Sox9EGFP  cells by introducing these cells into a
culture system that facilitates formation of crypt/villus-like structures from a single cell (15). Subsequently,
genetic lineage tracing has shown Sox9 to mark multipotent IESCs in vivo (13).
While considerable efforts have been made to define the genetic signature of small intestine epithelial cells
(2, 9, 10, 15, 17, 18, 25, 26, 30, 37, 41–44), fewer studies have focused on identifying genetic biomarkers
of colonic epithelial stem cells (CESCs) (11, 13, 36, 39). The concept of two populations of CESCs has
been postulated: one is a slowly dividing label-retaining population, and the other is an actively dividing
high-turnover population (19). Two genetic lineage-tracing studies describe Lgr5 and Sox9 as biomarkers
of small IESCs and CESCs (13, 39). Two other candidate biomarkers, β -integrin and Phlda1 (Pleckstrin
homology-like domain family A member 1), localize to the stem cell zone in the colon (11, 36). Phlda1
demonstrates a restricted expression pattern to the base of the crypt and appears to be consistent with Lgr5-
expressing cells (36). FACS-isolated β -integrin cells demonstrated the ability to form colonies in culture;
however, at the time of this study, culture conditions did not permit testing of whether the β -integrin cells
were multipotent and self-renewing (11). It is currently unknown whether any of these putative or
established stem cell biomarkers demonstrate overlapping expression patterns with a label-retaining or
high-turnover CESC population.
SOX9 exhibits a broader crypt expression pattern in the colonic crypts compared with the crypts of the
small intestines (4, 10); however, like the small intestine, different levels of Sox9EGFP (and SOX9) are
regionally restricted to the progenitor and stem cell zones. Therefore, we hypothesized that distinct levels
of Sox9 could serve as useful biomarkers for CESCs and progenitor populations in the colon. This study
describes the cellular and molecular characterization of CESCs that express Sox9. We quantify different
levels of Sox9 in single cells of the colonic crypt base and in cells of colon tumors from both mice and
humans using confocal microscopy and computational image analysis. We assess the stemness of colonic
epithelial cells exhibiting different Sox9 expression levels. Additionally, we define culture conditions that
support colonoid formation from single CESCs. These studies provide a strong framework for
identification of other novel markers of CESCs and facilitate investigation into the behavior of CESCs in
disease models of the colon.
EXPERIMENTAL PROCEDURES
low
1
1
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Epithelial cell dissociation/FACS.
cDNA preparation/real-time PCR analysis.
The Sox9EGFP mouse line was originally generated as part of the GENSAT Brain Atlas Project (14) and
contains genomic integration of a modified bacterial artificial chromosome (BAC) (RP32–140D18) with
75.5-kb upstream and 151-kb downstream sequence to Sox9. Frozen Sox9EGFP mouse embryos were
obtained from the Mutant Mouse Regional Resource Center (University of California-Davis) and
reconstituted by transfer into foster mice. All mice are on the outbred CD-1 strain and were maintained as
heterozygotes on the CD-1 genetic background. Mice breed normally and live to adulthood with no overt
phenotypes due to the transgene. At 10 days postnatal, tail snips were viewed under an epifluorescent
microscope fitted with filters for EGFP visualization. A high level of EGFP fluorescence compared with
transgene negative control mice was scored as positive for the Sox9EGFP transgene.
The distal colons from three freshly killed 6- to 8-wk-old Sox9EGFP
mice were removed, flushed of luminal contents with ice-cold Hanks' balanced salt solution (HBSS), and
incubated at 37°C for 1 h in 5 ml of colonic epithelium dissociation medium I [CEDM I; Dulbecco's
modified eagle medium-high glucose (DMEM-H) containing 1 U/ml penicillin, 1 μg/ml streptomycin, 2.9
μg/ml අ-glutamine, 1% fetal bovine serum (FBS), 5 mM calcium chloride, 150 U/ml collagenase XI
(Sigma, St. Louis, MO), and 0.03 U/ml dispase (BD Biosciences, Franklin Lakes, NJ)]. The tissues were
washed once in 50 ml DMEM-H, and once in 50 ml PBS, and then transferred to CEDM II [CEDM II: PBS
containing 60 mM EDTA, 3 mM dithiothreitol, 10 μM anoikis inhibitor Y27632 (Sigma, St. Louis, MO)],
and incubated on ice for 20 min. Tissues were removed and transferred to CEDM III (CEDM III: PBS
containing 60 mM EDTA, and 10 μM Y27632) for 10 min at 37°C. Next, the tissue was shaken vigorously
for 1 min in CEDM III. The remnant tissue (muscularis) was then removed from CEDM III, and
dissociated crypts were pelleted at 820 g at 4°C for 5 min. The crypts were washed in 10 ml ice-cold
Dulbecco's phosphate-buffered saline (GIBCO), pelleted at 1,280 g, and incubated at 37°C for 10 min in
CEDM IV [CEDM IV: HBSS (GIBCO) containing 1.35 U/ml dispase and 10 μM Y27632]. Crypts were
shaken vigorously every 2 min to further dissociation into single cells. FBS was then added to 10%
(vol/vol), and the suspension was sequentially filtered through a 70-μm filter and then a 40-μm filter. The
final single-cell suspension was pelleted at 1,280 g at 4°C for 5 min and washed thrice in 10 ml of ice-cold
DMEM-H containing 10% FBS, 1 U/ml penicillin, 1 μg/ml streptomycin, 2.9 μg/ml අ-glutamine, and 10
μM Y27632. Between each wash step, the cells were pelleted at 1,280 g for 5 min at 4°C. The cell pellet
was resuspended in 2 ml of colonoid culture medium [CCM; advanced DMEM-F12, N2, B27 supplements,
1 U/ml penicillin, 1 μg/ml streptomycin, 2.9 μg/ml අ-glutamine (GIBCO), 10 μM HEPES buffer
(Invitrogen), supplemented with 10 μM Y27632, and 25 μg/ml DNase I before FACS].
Sox9EGFP forward-side scatter gating was used to exclude 99.8% of all dead cells and lymphocytes. Both
forward scatter and side scatter height-area plots were used for doublet discrimination to maximize efficient
single-cell sorting. Sort gates for populations 1, 2, and 3 were based on the natural peaks that were present
on the univariate EGFP histogram. Cells were collected in ice-cold CCM supplemented with 10 μM
Y27632 (Sigma, Saint Louis, MO) and kept on ice throughout the sort.
Total RNA was isolated from 0.25–0.5 × 10  cells
(populations 1, 2, and 3) using RNAqueous Micro Kit 9 (Ambion, Austin, TX), according to the
manufacturer's protocols. cDNA was generated using High Capacity cDNA kit (Applied Biosystems,
Pleasanton, CA). Time from tissue harvest to RNA extraction was kept in between 3.5–4 h to control the
quality of RNA. Real-time PCR was conducted for each sample in triplicate on 1/250 of the total amount
of cDNA generated. Taqman probes for each gene (18S, HS99999901; Atoh1, Mm00476035_s1; ChgA
Mm00514341_m1; Lgr5, Mm00438890_m1; Notch1, Mm00435245_m1; Sox9, Mm00448840_m1; Tff3,
Mm00495590_m1) were used in real-time PCR reactions, according to the manufacturer's protocols. 18S
ribosomal RNA was amplified and used as the internal control gene for sample comparison. ΔΔCT values
were calculated to obtain fold changes for sample comparison (29). Due to mosaic Sox9EGFP expression
that is unique to the colonic epithelium, we normalized fold changes to population 1, which exhibited the
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CESC culturing/intestinal myofibroblasts isolation.
Immunostaining/microscopy.
lowest levels of Sox9EGFP expression. All data points represent means ± SE from three separate
experiments; statistical analysis was conducted by one-way ANOVA and post hoc Tukey-Kramer pairwise
tests. A P value of <0.05 was considered statistically significant.
E16.5 embryonic intestinal myofibroblasts (MFs)
were isolated from a transgenic mouse model in which the red fluorescent reporter gene, dsRED is driven
by the smooth muscle actin (SMA) promoter (21). A CD-1 female was time-mated with a SMA-DsRED
male mouse. Embryos were collected at 16.5 days postcoitus and phenotyped for expression of SMA
by visualization under fluorescent microscopy. Intestines were dissected from SMA -positive embryos
with the aid of a dissecting microscope and rinsed in sterile, ice-cold PBS to remove any adherent
nonintestinal tissues. Special care was taken to assure no embryonic liver remained in the cell prep. Tissue
was minced into 1-mm  pieces and transferred to a 50-ml conical containing 5 ml DMEM-H (GIBCO)
with 0.3 U/ml dispase (Collaborative Biomedical) and 300 U/ml collagenase I (Sigma). The tissue slurry
was rotated for 30 min at room temperature before 10 ml of DMEM-H +10% FBS (Gemini) was added.
The slurry was then pipetted vigorously 50 times to mechanically dissociate any remaining clumps of cells.
The cells were centrifuged for 5 min at 460 g, resuspended in DMEM-H with 10% FBS, and plated in a 10-
cm culture dish. Cells underwent three passages to obtain a pure population of dsRED-positive MFs before
use in colonoid culture. Flow cytometry demonstrated that >98% of cells were dsRED-positive.
Ten thousand sorted cells from each gate (1, 2, or 3) were individually pelleted at 3,000 g for 5 min, the
media was carefully removed, and 3 μl of media were added to the cell pellet, which was resuspended by
pipetting. The cells were added to 50 μl of ice-cold growth factor reduced Matrigel (BD, Franklin Lakes,
NJ) supplemented with 1 μg/ml of mR-Spondin1 (R&D Systems, Minneapolis, MN), 1 μM Jagged-1
(AnaSpec, San Jose, CA), 100 ng/ml Noggin (Peprotech, Rocky Hill, NJ), 80 ng/ml Wnt3a (R&D Systems,
Minneapolis, MN), and 50 ng/ml epidermal growth factor (EGF) (R&D Systems) and thoroughly mixed by
pipetting. The cell/Matrigel mixture was plated on a Transwell insert designed for a 24-well plate format.
The Matrigel was allowed to polymerize for 30 min at 37°C. The Transwells were placed into the 24-well
plate, which contained E18.5 MFs that were 30–50% confluent. Two-hundred and fifty microliters of CCM
with 10 μM Y27632 were added to the well containing the MFs, and 200 μl of CCM were added to the
Transwell insert (500-μl total volume). Growth factors were replenished every 2 days by diluting the
factors (R-spondin1, Wnt3a, Noggin, EGF) in a volume of growth medium, such that 10 μl represented a
50× solution of concentrations described above. Growth medium containing R-spondin, Wnt3a, Noggin,
and EGF at 1× concentrations was completely changed every 4 days.
For passaging experiments, colonoids were isolated from Matrigel with a pipette and transferred to
advanced DMEM/F12 with 10 μM Y27632 in 2.0 ml conical tubes. Single cells were obtained by addition
of dispase (0.3 U/ml), incubation for 20 min at 37°C, and combined with trituration 20× through a 10-ml
pipette connected to a mechanical pipettor. If cells were not dissociated to satisfaction, another 20
triturations were performed. Cells were pelleted and washed twice in advanced DMEM/F12, containing
10% FBS and 10 μM Y27632. Cells were washed once in advanced DMEM/F12, pelleted at 3,000 g, and
replated in Matrigel, as described above.
For tissue preparation, small intestines were dissected from adult
Sox9EGFP mice (>8 wk of age), and luminal contents were flushed out with PBS, followed immediately
by a single flush with freshly prepared 4% paraformaldehyde. The colon was opened along the proximal-
distal axis and fixed for an additional 14–18 h at 4°C. The tissues were then prepared for cryosectioning by
immersion in 30% sucrose solution for at least 24 h at 4°C. Tissues were then embedded in optimal cutting
temperature (OCT) medium and frozen on dry ice. The OCT blocks were stored at −80°C until
cryosectioning. Thin sections (8–10 μm) were cut on a cryostat and placed on positively charged
microscope slides for staining and microscopy. This tissue preparation technique is critical for preserving
dsRed
dsRed
2
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Image analysis.
Sox9 expression levels vary between cells in the normal colonic epithelium.
the EGFP fluorescence. Human colon tumor samples were obtained from US Biomax (Rockville, MD).
Twenty-four cases were contained on a tissue microarray (TMA; serial no. CO482). Paraffin was removed
from the TMA using Histoclear, and immunostaining was conducted as described for mouse tissues.
For immunostaining, the sections were washed twice in PBS to remove OCT, followed by incubation in
blocking medium (5% normal goat or donkey serum), in PBS-0.3% Triton X-100 for at least 30 min at
room temperature (21–25°C). Primary antibodies were applied to the tissue sections in antibody-staining
solution (1% normal goat serum, in PBS-0.3% Triton X-100). Dilutions were as follows: α-lysozyme
(rabbit, 1:1,000, Diagnostics Biosystems, Pleasanton, CA, RP 028), α-mucin 2 (rabbit; 1:100, Santa Cruz
Biotechnology, Santa Cruz, CA, sc-15334), α-SOX9 (rabbit, 1:1,000, Chemicon, Temecula, CA, AB5535),
α-substance P (rat; 1:500, Chemicon, MAB356), α-chromogranin A (rabbit; 1:500, Immunostar, 20086),
and α-sucrase isomaltase (goat; 1:100, Santa Cruz Biotechnology, sc-27603). All secondary antibodies (α-
rabbit-Cy3, Sigma, St. Louis, MO, C2306; α-rabbit-Alexa fluor 488, Molecular Probes, Eugene, OR,
Z-25302; α-rat-Alexa fluor 555, Molecular Probes, Z-25305; α-goat-Cy3) were used at a 1:500 dilution in
staining buffer. Ki67 immunostaining required special conditions. Tissue sections were cut as described
above and were antigen retrieved using Reveal Buffer (Biocare Medical) for 10 s at 120°C in a pressure
cooker. Slides were allowed to cool at room temperature for 20 min and washed 3× in Tris buffer (TB; 0.05
M TrisꞏHCl; pH 7.6) for 2 min each. Ki67 (DAKO) was diluted 1:100 in DAKO diluent (DAKO) and
incubated in a humidified chamber for 2 h at room temperature. The Ki67 antibody solution was removed,
and the tissues were washed 3× in TB for 2 min each. Biotinylated anti-rat-IgG was diluted 1:100 in
DAKO diluent and applied to the tissue sections for 1 h at room temperature in a humidified chamber. The
secondary antibody was removed, and the tissue sections were washed 3× in TB, as described above. For
Ki67 detection, Alexa-fluor 555 streptavidin was diluted 1:250 in DAKO diluent and incubated with tissues
for 1 h at room temperature in a humidified chamber. The slides were then washed 3×, as described above,
and mounted using aqueous mounting medium. All nuclei were stained with Draq5 (1:10,000, Biostatus,
San Diego, CA, BOS-889–001). Background staining was negligible, as determined by nonspecific IgG
staining.
Day-to-day development of colonoids was tracked using light microscopy. Epifluorescence images were
captured on an Olympus IX70 fitted with an Olympus digital camera. Objective lenses used were ×20 and
×40, with numerical apertures of 0.55 and 1.40, respectively. All confocal images represent ×200 (1.0-μm
optical sections), ×400 (1.0-μm optical sections), or ×630 (1.0-μm optical sections). Objective lenses for
the confocal images had a numerical aperture of 0.1.
Images for quantifying individual cell fluorescence intensities were obtained using a Zeiss
LSM 510 confocal microscope at ×400 optical zoom with a 1.0-μm optical section. The red, green, and
blue images were stacked in the image analysis program, FIJI (NIH ImageJ). To measure the level of SOX9
immunostaining in individual cells, an oval was superimposed on the nucleus (blue channel), and the
“measure” feature was used to sequentially determine the average fluorescence intensity (or pixel intensity)
of the red and green wavelengths. The base of the crypt was defined as cell position 1, increasing to the
right and decreasing to the left. Measurement data were then transferred into Microsoft Excel for statistical
analysis. For each image, average fluorescence intensities were loaded into the analysis application “R” (R
Foundation for Statistical Computing, Vienna, Austria), and the kernel density estimate was computed and
plotted using the “kernel” function with Gaussian kernel and bandwidth set to 4.
RESULTS
Sox9 is expressed at
different levels in the small intestine epithelium, facilitating the histological identification and FACS
isolation of IESCs (10, 15). In the colon, Sox9EGFP is primarily expressed in the lower one-half of the
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Colonic tumor cells exhibit variable SOX9- or Sox9EGFP-expression levels.
Sox9 is expressed in undifferentiated proliferating cells and a subset of mucin 2 expressing cells.
crypt and is regionally separated from the more differentiated absorptive colonocytes, which express
carbonic anhydrase II (Fig. 1A). To determine whether Sox9 was expressed at different levels in the colonic
epithelium, we used a Sox9EGFP reporter gene mouse or immunostaining for endogenous SOX9 to
visualize Sox9 expression (Fig. 1B). The data qualitatively suggest that Sox9EGFP (and SOX9) are
expressed at variable levels, with higher Sox9EGFP expression in the crypt base and lower Sox9EGFP
expression in cells positioned closer to the luminal surface (Fig. 1A).
To quantitatively assess whether cells in the crypt base expressed higher levels of Sox9EGFP and SOX9,
image analysis software was used to analyze 1.0-μm confocal optical sections of Sox9EGFP colon that had
been stained for endogenous SOX9 (Fig. 2). The nuclei of individual cells in the images were digitally
marked (independent of Sox9 expression), and then Sox9EGFP and endogenous SOX9 levels in the marked
nuclear regions of corresponding images were quantified. Comparisons were conducted on a cell-by-cell
basis using the conventional crypt cell position method, where position “zero” is at the base of the crypt,
cells to the left of zero are sequentially designated by negative numbers, and cells to the right of zero are
sequentially designated as positive numbers. Single crypt analysis shows that endogenous SOX9 levels
trend with Sox9EGFP levels both at the single cell level and by location (Fig. 2A). Analyses of 20 crypts
show that higher levels of Sox9EGFP and SOX9 are expressed toward the base of the crypt, and lower
levels are expressed toward the luminal surface (Fig. 2B). The nonparametric Wilcoxon rank sum test
supports the hypothesis that the distribution of Sox9EGFP intensities is significantly higher in the crypt
base from cell positions −4 to +4. Together, these data indicate that Sox9EGFP/SOX9 expression in colonic
crypt cells is indeed variable, with higher levels in the crypt base cells (from positions −4 to +4) and lower
levels in cells toward the lumen (positions higher than −4/+4), suggesting that different Sox9 levels could
serve as useful biomarkers for distinct and localized cell lineages.
SOX9 is expressed in
colonic adenomas in mice and humans (3, 4, 20, 27, 33); however, Sox9 expression levels in individual
cells have not been examined. To determine whether differential expression of Sox9EGFP persisted in
murine adenomas, we treated Sox9EGFP mice with azoxymethane (AOM)/dextran sodium sulfate (DSS)
and examined the levels of Sox9EGFP in developed tumors. Confocal images of adenomas visually show
positive Sox9EGFP expression, while closer examination demonstrates differential Sox9EGFP expression
levels in cells of the tumor (Fig. 3A). Statistical kernel density estimation of the distribution of Sox9EGFP
is multimodal, indicating multiple levels of expression exist (Fig. 3B). To determine whether differential
levels of SOX9 were expressed in primary human tumors, we assessed SOX9 expression levels in
individual cells from TMAs containing primary tumor biopsies (Fig. 3C). Again, statistical kernel density
estimation of the distribution of SOX9 expression is multimodal, indicating all three human tumors show
multiple, differential levels of expression (Fig. 3D).
Like most SOX9-expressing cells in the small intestine crypts, a majority of the SOX9-expressing cells in
colonic crypts also express the Ki67 proliferation marker (Fig. 4A). We identified a minority subset of
SOX9-expressing cells that did not colocalize with the Ki67 proliferation marker (Fig. 4A; white arrows).
The basal nuclei and large mucous globules in the cytoplasm suggest these nonproliferating cells are goblet
cells (6). To determine the lineage identity of Sox9EGFP-expressing cells, we stained Sox9EGFP colonic
tissue for goblet and enteroendocrine cell biomarkers. Immunostaining demonstrates that enteroendocrine
cells (chromogranin A ; Fig. 4B) and goblet cells (MUC2 ; Fig. 4C) do not express detectable levels of
Sox9EGFP. Although the absence of endogenous SOX9 expression is consistent with the absence of
Sox9EGFP transgene in enteroendocrine cells (data not shown), a subset of MUC2+/Sox9EGFP-goblet
cells do express endogenous SOX9 (Fig. 4D). Thus, in the colonic epithelium, SOX9 is expressed in
CESCs/progenitors and a subset of goblet cells. Despite the inconsistent expression pattern of the
Sox9EGFP transgene and endogenous SOX9 in the crypt-based MUC2  populations, the transgene
+ +
+
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Increasing expression levels of Sox9 in colonic epithelial cells correlate with increased stemness.
Colonic epithelial cells expressing the highest level of Sox9EGFP by flow cytometry form colonoids
in culture.
faithfully recapitulates the endogenous gene in the proliferating stem/progenitor populations. The lack of
Sox9EGFP expression in the crypt-based MUC2  cells was exploited as a method to FACS exclude
MUC2  cells from putative CESC populations.
In
the small intestine epithelium, Sox9EGFP is expressed at different levels in the base of the crypts, and
distinct levels of EGFP fluorescence facilitate differential identification and FACS isolation of IESCs from
transit amplifying progenitors and enteroendocrine cells (15). To assess whether different levels of
Sox9EGFP expression observed in the colonic epithelium could be used in a similar manner to isolate
CESCs, flow cytometry was used to analyze the Sox9EGFP levels in dissociated colonic epithelial cells (
Fig. 5). The results show three different Sox9EGFP-expressing populations, which are defined by three
distinct EGFP peak intensities (Fig. 5A). “Population 1” was defined by cells expressing the lowest levels
of Sox9EGFP, “population 2” by intermediate Sox9EGFP levels, and “population 3” by cells expressing
the highest levels of Sox9EGFP.
To characterize Sox9EGFP-expressing populations at the transcript level, FACS was used to differentially
isolate the three Sox9EGFP-expressing populations, and lineage identity was assessed by real-time RT-PCR
analysis of each population. Increasing endogenous Sox9 mRNA expression correlated with increasing
Sox9EGFP expression validating the FACS (Fig. 5, B and C). Previous studies using genetic lineage tracing
have identified that Lgr5 marks a CESC population in vivo (39). Population 3, which is most enriched for
Sox9 mRNA, also demonstrates significant enrichment of Lgr5 mRNA, compared with population 1,
suggesting that higher levels of Sox9EGFP correlate with increased “stemness” in the colon (Fig. 5D).
Notch pathway activation has been demonstrated to be essential for maintaining stemness (16, 35, 40).
When the Notch pathway is downregulated, there is an increase in Atoh1 expression, which results in
secretory lineage specification in transit amplifying progenitor cells. The data demonstrate a modest but
significant decrease in Notch1 mRNA in the population 1, which expresses the lowest level of Sox9, and
more notably a significant increase in secretory progenitor cell marker, Atoh1, mRNA in population 1.
These data indicate that lower levels of Sox9EGFP mark cells consistent with transit amplifying progenitor
cells (Fig. 5, E and F). Additionally, there was increased mRNA expression associated with goblet cells
(Tff3) and enteroendocrine cells (chromogranin A) in cells that expressed the lowest levels of Sox9EGFP (
Fig. 5, G and H). It is noteworthy that neither goblet cells nor enteroendocrine cells are observed to express
Sox9EGFP by fluorescence microscopy; however, the high sensitivity of EGFP detection by flow
cytometry is likely detecting small amounts of EGFP, even in cells that have downregulated Sox9EGFP and
upregulated Muc2 and ChgA upon differentiation. Taken together, these data strongly suggest that higher
levels of Sox9EGFP/Sox9 mark CESCs, and lower levels mark differentiating progenitors.
Recent advances in culturing techniques for small intestine IESCs have revolutionized single-cell analysis
of putative IESC populations that are initially identified and FACS isolated based on their gene expression
signatures. It should be stated that a true clonogenic assay in which validated single cells are FACSed into
individual wells has not been developed for IESCs, but, rather, single cells are typically FACS isolated and
plated together as putative singlets into a three-dimensional culture system. Sato et al. (39) first described
the culture system that supported the development of crypt/villus-like structures from single IESCs in the
absence of mesenchymal support cells. These culture conditions provide essential signaling that is usually
supplied by the nonepithelial cells in vivo, namely, a laminin-enriched extracellular matrix, EGF; Wnt-
pathway agonist, R-Spondin1; Notch-receptor agonist, Jagged; and bone morphogenic protein antagonist,
Noggin (39). A subsequent study from the same group indicated that a “support cell” is likely required to
produce mitogens and morphogens to FACS-isolated IESCs, which would promote survival and growth of
single IESCs in culture. In the absence of a more precise clonogenic assay, we utilized the strategy
+
+
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developed by Sato et al. (39) to assess the stemness of Sox9EGFP-expressing colonocytes.
To test whether distinct Sox9 levels correlated with functional stemness, we FACS isolated single
Sox9EGFP cells from populations 1, 2, and 3 and introduced these cells into the culture conditions that
support the development of small intestine organoids. Forty-eight hours postplating, no viable cells
remained, based on absence of Sox9EGFP expression and morphological characteristics consistent with
widespread apoptosis. Recent studies indicate that a Paneth cell-derived WNT3a source is critical for the
high-efficiency development of small intestine organoids from single IESCs (38). Paneth cells are not
present in the colonic epithelium; however, we reasoned that a “Paneth cell equivalent” might be providing
WNT3a in vivo. The conditions that support generation of organoids from IESCs were modified to include
exogenously supplied recombinant WNT3a, as well as an underlying layer of MFs derived from embryonic
murine intestine. Pericryptal MFs have been implicated in the support of epithelial growth and
development by secreting mitogens and morphogens in the IESC zones (23, 32). These new conditions
supported development of mature colonoids, which formed from isolated whole crypts (Fig. 6A) and
FACS-isolated Sox9EGFP cells from population 3 (Fig. 6B). Early development of colonospheres, a
colonoid precursor defined as a multicellular sphere (with no crypt-like structures) possessing a
pseudolumen, developed from populations 1, 2, and 3 at an incidence of 0.3, 0.6, and 1.1%, respectively,
between 2 and 3 days postplating. However, by day 7, all colonospheres from populations 1 and 2 ceased
further development and died, while all colonospheres from population 3 progressed development to
colonoid stage by day 12. Colonoid development persisted through day 24, at which point the colonoids
were mechanically dissociated and replated. Each colonoid at day 12 derived from FACS-isolated CESCs
produced three independent colonoids upon passaging, indicating symmetric division and self-renewal
capacity of population 3 CECSs (data not shown).
To assess the multipotency of population 3 CECS, colonoids were sectioned and immunostained for
markers of postmitotic lineages. Sox9EGFP expression persisted in colonoids and showed variable
expression levels similar to those observed in vivo (Fig. 7). Epithelial cell adhesion molecule staining
demonstrated that all cells were epithelial in nature (Fig. 7A). Chromogranin A and MUC2 expression
indicated that population 3 CESCs were competent to generate enteroendocrine (CHGA ) and goblet cells
(MUC2 ) (Fig. 7, B and C). MUC2 staining in the pseudolumen of the colonoids also indicates that the
cells derived from single CESCs are polarized and functional (Fig. 7C; middle). Carbonic anhydrase II
expression is consistent with absorptive colonocytes that localize to more luminal regions in vivo (Fig. 7D;
see Fig. 1A). Together these data indicate that population 3 CESCs characterized by the highest Sox9 levels
are multipotent and self-renewing.
DISCUSSION
Despite recent and rapid advances in the identification of stem cell biomarkers across nearly all tissue
types, precise cell-specific gene expression levels and the phenotypic consequences of these levels remain
an understudied metric of mechanisms regulating stem cell maintenance and differentiation. Technologies
that enable detection and monitoring of a gene's expression are becoming more robust, and the threshold of
these detection methods is sufficient to enable quantification of gene expression in single cells. We propose
that precise gene expression levels, and not simply the “on/off” qualitative parameter of gene expression,
may be a more robust and critical identifier of cellular phenotype than previously appreciated.
In past studies, we have demonstrated this concept by using differential Sox9 expression at the cellular level
to identify and isolate stem and progenitor cells from the small intestine epithelium (15). Other independent
studies have used differential levels of Lgr5EGFP expression in the small intestine to demonstrate that
“high” Lrg5EGFP-expressing cells are more stem-like, and “low” Lgr5EGFP-expressing cells are more
consistent with transit amplifying progenitor cells (43). In the present study, we further validate this
+
+
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concept by showing that higher Sox9-expression levels mark cells that have gene expression signatures and
functional characteristics of CESCs, while lower Sox9-expression levels are consistent with more
differentiated cell types. Importantly, we also demonstrate that the presence of Sox9 expression in colonic
epithelial cells is not, in and of itself, a sufficient indicator of stemness, as progenitor cells and subsets of
goblet cells also express Sox9. These findings indicate that, while in vivo lineage tracing remains a
powerful assay of stemness, careful analysis of cell-specific gene expression levels and the phenotypes
associated with these levels are necessary criteria when defining and validating stem cell biomarkers.
We have demonstrated that colonic epithelial cells expressing the highest levels of Sox9EGFP also
coexpress the highest levels of Lgr5, suggesting that these cells have functional stem cell qualities. Recent
breakthroughs in culturing of isolated IESCs from the small intestine provided us with a framework to
identify conditions that would support colonoid growth (15, 38, 39). The conditions described by Sato et al.
(38, 39) for culture of small intestine IESCs did not support growth of colonoids from CESCs. We
identified that additional requirements of WNT3a, in combination with critical unidentified diffusible
factors from an underlying MF layer, were essential to support generation of colonoids from single cells.
WNT3a is a secreted signaling protein that binds to receptors of the Frizzled family and has critical
developmental roles in proliferation control and morphogenesis (24). Additionally, WNT3a has been shown
to promote tissue-specific stem cell proliferation and maintenance in vitro (28, 34, 45). A recent study
suggests that Paneth cells in the small intestine supply WNT3a to the small intestine IESCs and are
required for maintenance of the IESC niche (38). Our studies demonstrate that WNT3a is essential for the
growth of CESCs in culture, and we speculate that the WNT3a source in the colon could be generated from
a similar cell type that is intimately associated with the CESCs. Our data suggest that this cell type is
consistent with a Sox9-expressing goblet cell that is intimately connected to the CESCs in a manner similar
to that of Paneth cells and IESCs in the small intestine. Moreover, both the crypt-based goblet cells and
Paneth cells express Sox9, indicating a conserved role for this transcription factor in differentiated cell
types that comprise the stem cell zone.
Interestingly, the Sox9EGFP transgene is not expressed in either MUC2+ cells in the base of the colonic
crypt or Paneth cells in the small intestine, despite the expression of endogenous SOX9 in these cells types
(10, 15). The Sox9EGFP transgene is randomly integrated into the genome; thus the disparity between the
Sox9EGFP transgene expression and endogenous SOX9 expression could be due to genome position
effects. It is also possible that the regulatory elements for Sox9 expression in crypt-based Paneth cells and
goblet cell types are not contained in the BAC construct. If the latter is true, then efforts to identify the cis-
regulatory elements required for lineage-specific Sox9 expression in Paneth cells and crypt-based goblet
cell expression could be focused to genomic regions that flank the BAC ends. Identifying these regulatory
elements could provide important insights into upstream signaling mechanisms that maintain Sox9 in cell
types that support the IESC and CESC niche.
The ability to identify and isolate cancer cells based on their gene expression profiles and associated
phenotypic characteristics has been central to the study of carcinogenesis (7, 46). Currently, the nature of
how individual cells contribute to colon cancer growth and invasion remains controversial, as technological
limitations have precluded the ability to precisely identify colon cancer stem cells. In this study and others,
we have shown that Sox9EGFP levels vary between cell types with different lineage identities and
functional stem cell characteristics in normal physiology (10, 15). A novel finding from our studies is that
these variable levels are preserved in cells of AOM/DSS mouse colon tumors and primary human tumors.
Based on the result from this study that higher levels of Sox9 expression correlate with increased stemness
in physiological states, the quantitative assessment of the ratio of higher vs. lower Sox9-expressing cells
within a tumor may provide an indication of cancer cell stemness. Further investigation into the levels of
SOX9 in cancer cell stemness holds promise as a diagnostic tool to predict outcomes and direct therapeutic
interventions.
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Prevailing evidence suggests that Sox9 has anti-oncogenic properties, in that higher levels suppress
proliferation and decrease Wnt signaling activity (4, 10). Interestingly, a new splice variant of SOX9 has
been recently identified in human cancer cell lines and primary tumors that appear to exhibit oncogenic
properties (1). The SOX9 splice variant (termed miniSox9) retains intron 2, producing in a premature stop
codon and an aberrant COOH-terminus. The mutant protein retains the DNA binding domain, but lacks the
transactivation domain. MiniSox9 inhibits the anti-oncogenic properties of full-length SOX9 and stimulates
the canonical Wnt pathway, presumably increasing proliferative capacity and tumorgenicity (1). The
miniSox9 study highlights the importance of characterizing the levels of Sox9 at the cellular level and also
understanding how these Sox9 levels mechanistically confer cellular phenotype. For example, determining
expression levels of full-length or miniSox9 in the same cell may identify subpopulations of cells within the
colonic tumors that have differential capacity for proliferation and differentiation.
The Sox9EGFP mouse model will be a useful tool to study the role of differential Sox9-expression levels in
cells of colon tumors. Currently, the Sox9EGFP mice are on a genetic background that is highly resistant to
AOM/DSS tumor induction; thus the amount of tumor tissue obtained in this study was insufficient for
gene expression analysis and culture assays at the single-cell level. On-going studies are underway to
introduce the Sox9EGFP allele onto genetic backgrounds that are more amenable to colonic tumor
induction. Based on our studies, we speculate that colonic adenoma cells expressing higher levels of Sox9
may exhibit slower division and more stem cell-like characteristics that have been hypothesized to be more
resistant to chemotherapy and radiation, while lower levels of Sox9 would be consistent with more rapidly
dividing progenitor-like cells that may be more responsive to standard cancer therapies (8). The concepts
and image analysis strategies developed in this study will enable detailed analysis of SOX9 levels in human
colonic adenomas and carcinomas and will likely establish rationale for screening tumor TMAs for
different levels of oncogenic gene products and correlating cellular expression levels of these oncogenic
proteins to clinical outcomes.
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Fig. 1.
Variations in Sox9EGFP/SOX9 expression levels in the base of colonic crypts. A, left: a gradient of Sox9EGFP and SOX9
cellular expression exists in colonic crypts. Increased Sox9EGFP and SOX9 levels localize to the crypt base, whereas
lower levels localize toward the lumen. Right: expression of Sox9EGFP is exclusive of the absorptive colonocyte
biomarker, carbonic anhydrase II (CAII). Images are ×200 original magnification. B: SOX9 and Sox9EGFP are expressed
at different levels in the crypt base, and the Sox9EGFP transgene recapitulates endogenous SOX9 expression. Images are
×630 original magnification.
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Fig. 2.
Confocal and computational image analysis demonstrates higher Sox9EGFP/SOX9 expression levels in the colonic crypt
base. A: single-cell image analysis. Sox9EGFP and SOX9 immunofluorescence intensities were measured on a cell-by-cell
basis and plotted as a function of cell position. Spearman rank correlation test indicated Sox9EGFP intensities correlated
with endogenous SOX9 fluorescence intensities by a significant dependence between endogenous SOX9 and enhanced
green fluorescent protein (EGFP) intensity distributions (r  = 0.69 with P < 2.2 × 10 ). B: Sox9EGFP levels form
distinct subgroups. Fluorescence intensities were averaged across 20 crypts for each cell position. When organized by
location into two subgroups at the crypt base (positions −4 to +4; solid circle) and higher (positions +/−5 to +/−10; shaded
circle), the distribution of Sox9EGFP intensities was significantly higher in the crypt base group compared with the TA
(transit amplifying) zone group (Wilcoxon rank sum test, P = 1.214 × 10  for EGFP, P = 3.482 × 10  for SOX9).
s −16
−6 −8
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Fig. 3.
Differential Sox9EGFP/SOX9 expression levels persist in cells of azoxymethane (AOM)/dextran sodium sulfate (DSS)
tumors in mice and in cells of primary human colon tumors. A: variable Sox9EGFP expression levels are preserved in
AOM/DSS adenomas. Region depicted in white box is magnified in right panel. Images represent 1-μm optical sections
imaged at ×200 (left) and ×400 (right) original magnification. B: Sox9EGFP fluorescence was quantified at the single-cell
level using the image analysis strategy described in Fig. 2. Multiple peaks in the histogram indicate a multimodal
distribution of different Sox9EGFP expression levels. C: three primary colon tumors from separate individuals were
immunostained for SOX9. The data visually demonstrate variable levels of SOX9 in tumor cells. D: single-cell
quantification of SOX9 expression in colon tumors demonstrates multimodal SOX9 expression and also different ratios of
lower and higher SOX9-expressing cells between tumors from different individuals.
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Fig. 4.
Open in a separate window
Sox9EGFP is expressed in proliferating cells and a subset of mucin 2 (MUC2+) cells. A: SOX9 colocalizes with
proliferative marker Ki67, except in select cells closer to the crypt base (white arrows). B: Sox9EGFP is not expressed in
chromogranin A+ (ChgA) cells. C: Sox9EGFP−/MUC2+ cells are intercalated between Sox9EGFP+/MUC2− cells (white
arrows). D: crypt-based Sox9EGFP−/MUC2+ cells express SOX9 (red nuclei). Images represent 1-μm optical sections
imaged at ×400 (A and D) and ×1,260 (B and C) original magnification.
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Fig. 5.
Three different Sox9EGFP-expressing populations can be identified by flow cytometery, and higher levels of Sox9EGFP
correlate with increased stemness. A: univariate flow cytometry histogram demonstrates a trimodal distribution of
Sox9EGFP intensity. B: postsort analysis of cells sorted using gates 1, 2, and 3 validate fluorescent-activated cell sorting
(FACS) based on increasing EGFP intensity. Images are ×200 original magnification with identical exposure time and
gain. Semiquantitative RT-PCR conducted on populations 1, 2, and 3 showed significant enrichment of Sox9 in population
3 (C), Lgr5, a known colonic epithelial stem cells (CESC) marker, in population 3 (D), and Notch1 in population 3 (E),
whereas Atoh1, a marker associated with secretory progenitors, was enriched in population 1 (F). Enrichment of
differentiated cell markers Tff3 (G) and ChgA (H) was observed in population 1. Statistical comparisons were performed
using one-way ANOVA with post hoc Tukey-Kramer pairwise comparisons; tests were considered significant if P < 0.05.
 The different letters above each bar represent data points that are statistically different from each other.a,b,c
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Fig. 6.
Open in a separate window
High Sox9EGFP expression can be used as a FACS parameter to isolate CESCs that form colonoids in culture. Colonoids
are defined as complex crypt-like bodies that develop from whole crypts or single CESCs. Colonoids are composed of
colonic epithelial cells surrounding a pseudolumen and do not contain a mesenchymal cellular component. By 3 days in
culture, both whole colonic crypts (A) and single CESCs (B) first develop into colonospheres that are composed of
epithelial cells that have not formed crypt-like structures but contain a pseudolumen. Colonospheres progress to colonoids
by 24 days in culture. Images were captured at ×200 original magnification.
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Fig. 7.
Open in a separate window
Sox9EGFP CECSs that form colonoids are multipotent. A: epithelial cell adhesion molecule (EpCAM) staining confirms
that colonoid cells are epithelial. ChgA (white arrow; B); MUC2 (white box indicates magnified region; C, right); and
CAII (D) immunostaining indicate Sox9EGFP CESCs are competent to generate enteroendocrine, goblet, and absorptive
colonocytes, respectively. Images represent 1-μm optical sections. Magnifications are indicated in each panel.
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